PMC/PubMed Indexed Articles
Indexed In
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Clinical Research & Bioethics have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Research & Bioethics has got h-index 19, which means every article in Journal of Clinical Research & Bioethics has got 19 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical Research & Bioethics.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
45 | 60 | 60 | 61 | 52 | 9 | 16 | 23 | 41 | 51 | 41 | 32 | 17 | 28 | 3 |
Research, Review articles and Editorials |
3 | 13 | 8 | 31 | 21 | 7 | 9 | 12 | 17 | 28 | 31 | 15 | 15 | 23 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
42 | 47 | 52 | 30 | 31 | 2 | 7 | 11 | 24 | 23 | 10 | 17 | 2 | 5 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 36 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
118 | 177 | 197 | 207 | 214 | 190 | 179 | 160 | 153 | 183 | 145 | 53 | 32 | 37 | 14 |
| Journal total citations count | 2248 |
| Journal impact factor | 1.91 |
| Journal 5 years impact factor | 2.41 |
| Journal cite score | 5.23 |
| Journal h-index | 19 |
Important citations
Crepelle A (2016) A Market for Human Organs: An Ethical Solution to the Organ Shortage. Ind. Health L. Rev.13: 17.
Canca C (2016) The unjustified policy against a market in kidneys. Asian Bioethics Review 8: 177-194.
Gordon EJ, Patel CH, Sohn MW, Hippen B, Sherman LA (2015) Does financial compensation for living kidney donation change willingness to donate?. American Journal of Transplantation 15: 265-273.
ŽUNJIĆ S. Filozofijom.
Pavlovic D. CV/Doctora students/List of publications.
richiamo della Foresta I. Navigazione principale. Romania. 2015 May 5.
FEDI B, MANZONI A, PENCO S, POCAR V, TERRILE M. CONTRO LA VIVISEZIONE E LA SPERIMENTAZIONE ANIMALE.
Koonrungsesomboon N, Laothavorn J, Karbwang J (2016) Ethical considerations and challenges in first-in-human research. Translational Research 177: 6-18.
Habets MG. Ethical challenges in translational pluripotent stem cell research: Justifying leaps of faith (Doctoral dissertation, Utrecht University).
Satalkar P, Elger BS, Shaw DM (2016) Stakeholder views on participant selection for first-in-human trials in cancer nanomedicine. Current Oncology 23: e530.
Habets MG, van Delden JJ, Bredenoord AL (2016) The unique status of first-in-human studies: strengthening the social value requirement. Drug Discovery Today.
Blog OF. Supporting data from experts.
Chapman AR (2012) Improving Subject Safety in High-Risk Phase I Trials With Stem Cell-Based Candidate Therapies. AJOB Neuroscience 3: 18-20.
Helmchen H (2013) Ethische Grundvoraussetzungen klinischer Forschung. InEthik psychiatrischer Forschung. Springer Berlin Heidelberg pp. 39-56.
Napier S (2013) Challenging research on human subjects: justice and uncompensated harms. Theoretical medicine and bioethics 34: 29-51.
Smith SE, Reeder SJ (2013) What nurse practitioners should know about gene therapy. The Nurse Practitioner 38: 16-22.
Satalkar P, Elger BS, Shaw D (2016) Naming it ‘nano’: Expert views on ‘nano’terminology in informed consent forms of first-in-human nanomedicine trials. Nanomedicine : 933-940.
Greek R (2014) The Ethical Implications for Humans in Light of the Poor Predictive Value of Animal Models. International Journal of Clinical Medicine.
Genske A, Engel-Glatter S (2016) Rethinking risk assessment for emerging technology first-in-human trials. Medicine, Health Care and Philosophy 19: 125-139.
Jones RC, Greek R (2014) A review of the Institute of Medicine’s analysis of using chimpanzees in biomedical research. Science and engineering ethics 20: 481-504.